IP Library Granted Patent US 10,160,784
Granted Patent B2
US 10,160,784 · App. 15/121,676 · Granted Dec 25, 2018

Antibody purification process

Inventor: Peter Stanley Gagnon (Singapore, SG)
Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
C07K1/30C07K1/32C07K16/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,160,784
App. No.
15/121,676
Granted
Dec 25, 2018
Kind
B2
Abstract

A method of purifying a target antibody includes contacting a cell culture harvest or a protein preparation including at least one target antibody with at least one fatty acid having 7 to 10 carbon atoms to form a mixture, contacting this mixture with allantoin, and then separating solid materials to provide a solution comprising the target antibody. Solid materials can be removed by filtration, sedimentation or centrifugation, and the fatty acids can be enanthic, caprylic, pelargonic, nonenoic or capric acid. The invention is also directed to kits used to facilitate this method of antibody purification.

Claims (23)

1. A method of purifying an antibody comprising:

(a) contacting a cell culture harvest or a protein preparation comprising at least one antibody with at least one fatty acid having 7 to 10 carbon atoms to form a mixture;

(b) contacting the mixture with allantoin; and

(c) removing solid materials from the IgG-containing liquid.

2. The method of claim 1 , wherein the allantoin is present at a concentration in a range selected from the group consisting of: (a) from about 0.6 to about 30%, (b) from about 1 to about 10%, and (c) from about 1 to about 2%.

3. The method of claim 1 , wherein allantoin is in a range from a non-zero amount up to about 0.6%.

4. The method of claim 1 , wherein the solid materials are removed by sedimentation, centrifugation or combinations thereof.

5. The method of claim 1 , wherein the solid materials are removed by filtration.

6. The method of claim 5 , wherein the filtration comprises membrane filtration or depth filtration.

7. The method of claim 6 , wherein the membrane filtration or depth filtration comprises a contact surface that is functionalized.

8. The method of claim 1 , wherein the cell culture harvest or protein preparation contains cells, and optionally resides in a bioreactor in which cell culture production was performed.

9. The method of claim 1 , wherein the cell culture harvest or protein preparation does not contain cells.

10. The method of claim 1 , wherein the protein preparation is a naturally occurring biological fluid.

11. The method of claim 1 , wherein the at least one fatty acid comprises a general structural formula of CH 3 (CH 2 ) n COOH, wherein n is an integer from 5 to 8.

12. The method of claim 1 , wherein the at least one fatty acid comprises enanthic (heptanoic) acid, caprylic (octanoic) acid, pelargonic (nonanoic) acid, or capric (decanoic) acid.

13. The method of claim 1 , wherein the at least one fatty acid contains at least one double bond.

14. The method of claim 13 , wherein the at least one fatty acid comprises nonenoic acid.

15. The method of claim 13 , wherein the at least one fatty acid comprises nonenoic acid with the double bond at the terminal position.

16. The method of claim 1 , wherein the at least one fatty acid is present at a concentration in a range selected from the group consisting of: (a) from about 0.05 to about 5%, (b) from about 0.1 to about 1.0%, (c) from about 0.2 to about 0.4%, and (d) from about 0.1 to 0.2%.

17. The method of claim 1 , wherein the mixture further comprises a surfactant.

18. The method of claim 17 , wherein the surfactant is nonionic, or zwitterionic, or cationic.

19. The method of claim 18 , wherein the cationic surfactant is cetyltrimethylammonium bromide.

20. The method of claim 19 , wherein the cetyltrimethylammonium bromide is present at a concentration ranging from about 0.001% to 0.05%, or from about 0.005% to 0.025%, or from about 0.0075% to about 0.01%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2018
From: GAGNON, PETER STANLEY
To: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
Reel/Frame 046713/0520 →
Continuity (1)
Related Publication 20160362446A1 · Dec 15, 2016